Allergy/Imm Medical News about Isoniazid

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Isoniazid in patient plasma may cause a false-positive result on the complement-dependent cytotoxicity test
Human Immunology, 09/02/09

Poli F et al. – The authors postulated that nonspecific binding of drug–antibody complexes to panel lymphocytes in the CDC test may have caused the observed lympholysis. This case, although isolated, emphasizes the importance of the combined use of CDC and solid phase assays. The CDC results alone would have led to the erroneous conclusion that the patient was highly sensitized.

<< Previous
Novel human leukocyte antigen class I and class II alleles...

Next >>
Increased number of CD16+CD56dim NK cells in peripheral blood...

Nontuberculous Mycobacterium Disease With Pleural Empyema in a Patient With Advanced AIDS
The American Journal of the Medical Sciences, 11/13/09 Relevance Score: 80%

Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis
The International Journal of Tuberculosis and Lung Disease, 10/30/09 Relevance Score: 80%

First documentation of isoniazid reversion in Mycobacterium tuberculosis
The International Journal of Tuberculosis and Lung Disease, 10/28/09 Relevance Score: 80%

Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis
Rheumatology International, 10/29/09 Relevance Score: 77%